Table 2 Demographic features of diagnostic and biomarkers groups.
SCD AP− | SCD AP+ | MCI AP− | MCI AP+ | AD-d | |
---|---|---|---|---|---|
N° 20 | N° 8 | N° 24 | N° 17 | N° 21 | |
Age at onset in years | 55.60 (± 9.69)*° | 62.50 (± 10.9 9) | 60.13 (± 11.45)^ | 70.31 (± 5.26)*^ | 64.76 (± 5.38)° |
Age at plasma collection | 62.83 (± 8.33)+# | 73.63 (± 6.05)+ | 67.92 (± 8.71) | 74.06(± 5.54) | 69.26 (± 5.45)# |
Disease duration | 5.15 (± 6.18) | 10.25 (± 6.34)&@ | 5.65 (± 6.77) | 3.33 (± 3.16)& | 2.57 (± 3.46)@ |
Family history of AD | 85.00%§ | 75.00% | 58.33% | 64.70% | 52.38%§ |
Sex (M–F) | 4–16 | 4–4 | 8–16 | 7–10 | 10–11 |
Years of education | 13.05 (± 3.32) | 12.63 (± 5.09) | 11.46 (± 4.55) | 13.88 (± 3.87) | 10.47 (± 5.34) |
MMSE | 28.03 (± 1.56)ç | 27.63 (± 2.10)£ | 26.18 (± 2.03)$ | 25.48 (± 2.18)€ | 20.70 (± 5.02)ç,£,$,€ |
APOE ɛ4+ | 35.00%α | 37.50% | 16.66%β,γ | 76.47%β | 61.90%α,γ |
Impaired renal function | 0 | 0 | 1 (4.16%) | 0 | 0 |
Log p-tau181 (pg/ml) | 0.23 (± 0.16)a,b,c | 0.44 (± 0.08)a,d | 0.22 (± 0.26)d,e,f | 0.57 (± 0.13)b,e | 0.59 (± 0.14)c,f |
Log NfL (pg/ml) | 1.07 (± 0.12)g,h,i | 1.33 (± 0.18)g,l | 1.11 (± 0.17)l,m,n | 1.32 (± 0.20)h,m | 1.29 (± 0.12)i,n |